The 45 rating InvestorsObserver gives to Avadel Pharmaceuticals PLC (AVDL) stock puts it near the top of the Drug Manufacturers - Specialty & Generic industry. In addition to scoring higher than 76 percent of stocks in the Drug Manufacturers - Specialty & Generic industry, AVDL’s 45 overall rating means the stock scores better than 45 percent of all stocks.
What do These Ratings Mean?
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With Avadel Pharmaceuticals PLC Stock Today?
Avadel Pharmaceuticals PLC (AVDL) stock has risen 6.55% while the S&P 500 has fallen -2.43% as of 3:58 PM on Monday, Oct 26. AVDL has risen $0.35 from the previous closing price of $5.34 on volume of 449,520 shares. Over the past year the S&P 500 is higher by 11.25% while AVDL has risen 30.80%. AVDL earned $0.11 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 51.78.